InMed Pharmaceuticals (INM) Short Interest Ratio & Short Volume $2.62 -0.16 (-5.76%) Closing price 04:00 PM EasternExtended Trading$2.66 +0.04 (+1.72%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock InMed Pharmaceuticals Short Interest DataInMed Pharmaceuticals (INM) has a short interest of 215,700 shares, representing 18.13% of the float (the number of shares available for trading by the public). This marks a 555.62% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 1.01 million shares to cover all short positions.Current Short Interest215,700 sharesPrevious Short Interest32,900 sharesChange Vs. Previous Month+555.62%Dollar Volume Sold Short$701.03 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJune 30, 2025Outstanding Shares1,210,000 sharesShort Percent of Float18.13%Today's Trading Volume95,504 sharesAverage Trading Volume1,007,359 sharesToday's Volume Vs. Average9% Short Selling InMed Pharmaceuticals? Sign up to receive the latest short interest report for InMed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINM Short Interest Over TimeINM Days to Cover Over TimeINM Percentage of Float Shorted Over Time InMed Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025215,700 shares $701.03 thousand +555.6%18.1%0.1 $3.25 6/15/202532,900 shares $83.24 thousand -33.7%2.8%0 $2.53 5/31/202549,600 shares $122.51 thousand -46.0%7.0%0 $2.47 5/15/202591,900 shares $270.19 thousand +191.8%12.9%1 $2.94 4/30/202531,500 shares $93.87 thousand -27.6%N/A0.8 $2.98 4/15/202543,500 shares $120.93 thousand +58.2%6.1%0.8 $2.78 3/31/202527,500 shares $56.93 thousand +26.7%3.9%0.1 $2.07 3/15/202521,700 shares $61.19 thousand -19.3%3.1%0 $2.82 2/28/202526,900 shares $79.09 thousand -25.1%3.8%0.1 $2.94 2/15/202535,900 shares $113.44 thousand +8.5%5.0%0.1 $3.16 Get the Latest News and Ratings for INM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InMed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202533,100 shares $101.95 thousand +1,125.9%N/A0.1 $3.08 1/15/20252,700 shares $11.72 thousand -71.0%N/A0 $4.34 12/31/20249,300 shares $44.08 thousand -30.1%N/A0.2 $4.74 12/15/202413,300 shares $69.96 thousand +3.9%N/A0.3 $5.26 11/30/202412,800 shares $54.91 thousand -50.6%N/A0.3 $4.29 11/15/202425,900 shares $110.85 thousand -77.6%N/A0.5 $4.28 10/31/2024115,500 shares $30.71 thousand +188.8%N/A0 $0.27 10/15/202440,000 shares $8.76 thousand -57.1%N/A0 $0.22 9/30/202493,200 shares $22.09 thousand -82.6%N/A0 $0.24 9/15/2024534,900 shares $139.82 thousand +55.3%N/A0.1 $0.26 8/31/2024344,500 shares $122.26 thousand +818.7%N/A0 $0.35 8/15/202437,500 shares $5.40 thousand -85.2%N/A0 $0.14 7/31/2024253,200 shares $44.51 thousand +85.2%N/A0.2 $0.18 7/15/2024136,700 shares $36.46 thousand +61.4%N/A0.1 $0.27 6/30/202484,700 shares $22.49 thousand -43.5%N/A0.1 $0.27 6/15/2024150,000 shares $34.01 thousand +252.9%N/A0.2 $0.23 5/31/202442,500 shares $12.54 thousand -44.6%N/A0.1 $0.30 5/15/202476,700 shares $21.02 thousand -78.6%N/A0.2 $0.27 4/30/2024359,000 shares $96.57 thousand +213.5%N/A0.9 $0.27 4/15/2024114,500 shares $36.49 thousand +1,011.7%N/A0.3 $0.32 3/31/202410,300 shares $3.75 thousand -81.9%N/A0 $0.36 3/15/202457,000 shares $20.52 thousand -13.9%N/A0.3 $0.36 2/29/202466,200 shares $27.47 thousand -52.1%N/A0.3 $0.42 2/15/2024138,300 shares $47.99 thousand +244.9%N/A0.7 $0.35 1/31/202440,100 shares $14.43 thousand -43.4%N/A0.2 $0.36 1/15/202470,800 shares $27.08 thousand -47.2%N/A0 $0.38 12/31/2023134,000 shares $55.74 thousand +1,213.7%N/A0.1 $0.42 12/15/202310,200 shares $3.67 thousand -65.9%N/A0 $0.36 11/30/202329,900 shares $13.16 thousand +510.2%N/A0 $0.44 11/15/20234,900 shares $1.99 thousand -74.1%N/A0 $0.41The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again. 10/31/202318,900 shares $9.14 thousand +339.5%N/A0 $0.48 10/15/20234,300 shares $2.74 thousand +377.8%N/A0 $0.64 9/30/2023900 shares $629.91 -90.1%N/A0 $0.70 9/15/20239,100 shares $7.68 thousand -65.4%N/A0.2 $0.84 8/31/202326,300 shares $21.59 thousand +64.4%N/A0.5 $0.82 8/15/202316,000 shares $14.96 thousand -61.5%N/A0.2 $0.94 7/31/202341,500 shares $46.48 thousand +112.8%N/A0.5 $1.12 7/15/202319,500 shares $18.72 thousand +2.6%N/A0.2 $0.96 6/30/202319,000 shares $17.48 thousand -63.2%N/A0.2 $0.92 6/15/202351,600 shares $65.53 thousand +4.7%N/A0.4 $1.27 5/31/202349,300 shares $66.06 thousand -24.0%N/A0.1 $1.34 5/15/202364,900 shares $75.28 thousand -30.8%N/A0.1 $1.16 4/30/202393,800 shares $112.56 thousand -25.7%N/A0.2 $1.20 4/15/2023126,300 shares $157.88 thousand +3.8%N/A0.2 $1.25 3/31/2023121,700 shares $131.44 thousand -27.7%N/A0.2 $1.08 3/15/2023168,400 shares $178.50 thousand +194.9%N/A0.2 $1.06 2/28/202357,100 shares $75.94 thousand -15.8%N/A0.1 $1.33 2/15/202367,800 shares $113.23 thousand -7.6%N/A0.1 $1.67 1/31/202373,400 shares $135.06 thousand -75.4%N/A0.1 $1.84 1/15/2023297,800 shares $562.84 thousand +443.4%3.8%0.3 $1.89 12/30/202254,800 shares $110.70 thousand +13.0%0.7%0.1 $2.02 12/15/202248,500 shares $90.21 thousand +62.8%0.6%0.1 $1.86 11/30/202229,800 shares $78.97 thousand +223.9%0.4%0 $2.65 11/15/20229,200 shares $25.58 thousand -32.9%0.1%0 $2.78 10/31/202213,700 shares $41.79 thousand +121.0%0.2%0 $3.05 10/15/20226,200 shares $32.92 thousand -83.9%0.1%0 $5.31 9/30/202238,600 shares $254.52 thousand -57.3%0.5%0 $6.59 9/15/202290,300 shares $867.78 thousand +12,800.0%1.2%0.1 $9.61 8/31/2022700 shares $4.17 thousand -89.4%N/A0 $5.95 8/15/20226,600 shares $2.57 thousand -62.5%0.1%0 $0.39 7/31/202217,600 shares $6.86 thousand -18.9%0.2%0.1 $0.39 7/15/202221,700 shares $8.03 thousand +6.4%0.3%0.1 $0.37 6/30/202220,400 shares $9.60 thousand -80.1%0.3%0.1 $0.47 6/15/2022102,300 shares $53.40 thousand +47.6%1.3%0.5 $0.52 5/31/202269,300 shares $53.36 thousand -29.4%0.9%0.3 $0.77 5/15/202298,100 shares $81.42 thousand -34.3%1.3%0.5 $0.83 4/30/2022149,300 shares $135.86 thousand -8.7%1.9%0.7 $0.91 4/15/2022163,600 shares $142.81 thousand +34.1%2.1%0.8 $0.87 3/31/2022122,000 shares $115.01 thousand +114.4%1.6%0.9 $0.94 3/15/202256,900 shares $41.02 thousand -35.3%0.7%0.6 $0.72 2/28/202287,900 shares $82.82 thousand +2.6%1.1%0.8 $0.94 2/15/202285,700 shares $99.41 thousand -2.7%1.1%0.3 $1.16 1/31/202288,100 shares $106.60 thousand -15.7%1.1%0 $1.21 1/15/2022104,500 shares $129.58 thousand +74.5%1.3%0 $1.24 12/31/202159,900 shares $78.47 thousand -8.4%0.8%0 $1.31 12/15/202165,400 shares $96.79 thousand -56.5%0.8%0 $1.48 11/30/2021150,400 shares $285.76 thousand +69.9%1.9%0.1 $1.90 11/15/202188,500 shares $118.59 thousand -19.7%1.1%0 $1.34 10/29/2021110,200 shares $168.06 thousand +69.3%1.4%0.2 $1.53 10/15/202165,100 shares $91.14 thousand -2.5%0.8%0.1 $1.40The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again. 9/30/202166,800 shares $116.90 thousand +189.2%0.8%0.3 $1.75 9/15/202123,100 shares $47.55 thousand +216.4%0.3%0.2 $2.06 8/31/20217,300 shares $16.13 thousand -92.4%0.1%0.1 $2.21 8/13/202196,600 shares $231.84 thousand -47.8%1.2%1.4 $2.40 7/30/2021185,100 shares $516.43 thousand +98.2%2.3%2.6 $2.79 7/15/202193,400 shares $249.38 thousand +396.8%1.2%1.3 $2.67 6/30/202118,800 shares $59.78 thousand +37.2%0.2%0.2 $3.18 6/15/202113,700 shares $39.05 thousand -2.8%0.2%0.2 $2.85 5/28/202114,100 shares $41.60 thousand +30.6%0.2%0.2 $2.95 5/14/202110,800 shares $30.35 thousand -90.7%0.1%0.1 $2.81 4/30/2021115,800 shares $431.93 thousand -14.7%1.5%0.7 $3.73 4/15/2021135,800 shares $435.92 thousand -64.8%1.7%0.7 $3.21 3/31/2021385,200 shares $1.21 million -6.6%4.8%1.8 $3.13 3/15/2021412,600 shares $1.96 million +0.3%5.2%1.8 $4.75 2/26/2021411,400 shares $1.80 million +7.3%5.9%1.7 $4.37 2/12/2021383,500 shares $2.05 million +177.1%5.5%1.6 $5.35 1/29/2021138,400 shares $546.69 thousand +63.2%2.0%0.6 $3.95 1/15/202184,800 shares $367.18 thousand No Change1.2%0.7 $4.33 INM Short Interest - Frequently Asked Questions What is InMed Pharmaceuticals' current short interest? Short interest is the volume of InMed Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 215,700 shares of INM short. 18.13% of InMed Pharmaceuticals' shares are currently sold short. Learn More on InMed Pharmaceuticals' current short interest. What is a good short interest percentage for InMed Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.13% of InMed Pharmaceuticals' floating shares are currently sold short. Is InMed Pharmaceuticals' short interest increasing or decreasing? InMed Pharmaceuticals saw a increase in short interest in June. As of June 30th, there was short interest totaling 215,700 shares, an increase of 555.6% from the previous total of 32,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does InMed Pharmaceuticals' short interest compare to its competitors? 18.13% of InMed Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to InMed Pharmaceuticals: Lexaria Bioscience Corp. (2.88%), HOOKIPA Pharma Inc. (1.58%), Ernexa Therapeutics Inc. (1.33%), Synlogic, Inc. (0.53%), Bullfrog AI Holdings Inc. (5.43%), Briacell Therap (5.20%), Leap Therapeutics, Inc. (9.27%), TherapeuticsMD, Inc. (14.02%), NKGen Biotech, Inc. (1.16%), IM Cannabis Corp. (12.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short InMed Pharmaceuticals stock? Short selling INM is an investing strategy that aims to generate trading profit from InMed Pharmaceuticals as its price is falling. INM shares are trading down $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against InMed Pharmaceuticals? A short squeeze for InMed Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INM, which in turn drives the price of the stock up even further. How often is InMed Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INM, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Lexaria Bioscience Short Interest HOOKIPA Pharma Short Interest Ernexa Therapeutics Short Interest Synlogic Short Interest Bullfrog AI Short Interest Briacell Therap Short Interest Leap Therapeutics Short Interest TherapeuticsMD Short Interest NKGen Biotech Short Interest IM Cannabis Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INM) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
